CRIS Current Research Information System

ANDRISANO, VINCENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 16.872
NA - Nord America 16.726
EU - Europa 13.248
AF - Africa 981
SA - Sud America 904
Continente sconosciuto - Info sul continente non disponibili 39
OC - Oceania 37
Totale 48.807
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.536
CN - Cina 4.703
SG - Singapore 4.380
VN - Vietnam 4.282
GB - Regno Unito 3.102
IT - Italia 3.083
DE - Germania 1.599
SE - Svezia 1.126
HK - Hong Kong 1.039
UA - Ucraina 963
IN - India 868
FR - Francia 810
RU - Federazione Russa 696
BR - Brasile 633
IE - Irlanda 415
KR - Corea 392
JP - Giappone 335
CI - Costa d'Avorio 325
ZA - Sudafrica 251
NL - Olanda 248
EE - Estonia 230
FI - Finlandia 184
TG - Togo 151
SC - Seychelles 132
BG - Bulgaria 121
CH - Svizzera 119
AR - Argentina 113
CA - Canada 112
ES - Italia 105
ID - Indonesia 96
PH - Filippine 89
TR - Turchia 85
PL - Polonia 84
BD - Bangladesh 82
JO - Giordania 69
TH - Thailandia 69
TW - Taiwan 64
BE - Belgio 60
MX - Messico 58
HR - Croazia 54
IQ - Iraq 51
IR - Iran 49
PK - Pakistan 48
EC - Ecuador 44
CZ - Repubblica Ceca 42
GR - Grecia 42
EU - Europa 38
AT - Austria 36
SA - Arabia Saudita 36
CL - Cile 32
AU - Australia 31
CO - Colombia 31
RO - Romania 30
NG - Nigeria 23
DK - Danimarca 21
MY - Malesia 21
LB - Libano 19
DZ - Algeria 18
UZ - Uzbekistan 17
MA - Marocco 16
AE - Emirati Arabi Uniti 15
EG - Egitto 15
VE - Venezuela 14
PT - Portogallo 13
TN - Tunisia 13
PY - Paraguay 12
KE - Kenya 11
LT - Lituania 10
HU - Ungheria 9
IL - Israele 9
AZ - Azerbaigian 8
BO - Bolivia 8
MD - Moldavia 8
NP - Nepal 8
PE - Perù 8
SI - Slovenia 8
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
SM - San Marino 7
GT - Guatemala 6
LK - Sri Lanka 6
UY - Uruguay 6
AL - Albania 5
AO - Angola 5
HN - Honduras 5
BA - Bosnia-Erzegovina 4
CY - Cipro 4
BH - Bahrain 3
CM - Camerun 3
CR - Costa Rica 3
ET - Etiopia 3
KG - Kirghizistan 3
PS - Palestinian Territory 3
SN - Senegal 3
BN - Brunei Darussalam 2
CG - Congo 2
JM - Giamaica 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
Totale 48.772
Salva come PNG Salva come JPEG
Città #
Singapore 3.001
Southend 2.620
Ashburn 1.867
Fairfield 1.324
Chandler 1.176
Ho Chi Minh City 976
Hong Kong 962
Santa Clara 906
Hanoi 804
Hefei 802
Houston 776
San Jose 753
Wilmington 746
Bologna 718
Jacksonville 667
Woodbridge 625
Dong Ket 619
Princeton 613
Seattle 560
Ann Arbor 503
Beijing 488
Cambridge 451
Dublin 414
Boardman 408
Abidjan 325
Seoul 302
Nanjing 296
Lauterbourg 288
Tokyo 288
Westminster 268
Padova 264
Los Angeles 241
Berlin 226
Dallas 197
Jinan 197
Milan 189
Shenyang 152
Helsinki 151
Lomé 151
Buffalo 150
New York 150
Medford 135
Da Nang 133
Saint Petersburg 130
Guangzhou 128
Changsha 118
Haiphong 116
Sofia 115
Mülheim 112
Turin 112
Redondo Beach 99
Council Bluffs 96
Falls Church 96
Tianjin 95
Nanchang 94
Hebei 90
Bengaluru 87
Shanghai 84
Mahé 83
Cesena 82
San Diego 82
Frankfurt am Main 79
Munich 77
Zhengzhou 76
Bern 74
Rome 74
São Paulo 72
Amman 69
Hải Dương 65
Dearborn 61
Jiaxing 61
Redmond 58
Bremen 56
Biên Hòa 55
Des Moines 55
Hangzhou 55
Haikou 50
Brussels 49
Carpi 48
Jakarta 47
Chicago 46
Taiyuan 45
Hyderabad 44
Norwalk 44
Phoenix 43
Verona 42
Warsaw 42
Forlì 41
Orem 41
London 40
Redwood City 40
Rimini 40
Can Tho 39
Cardiff 39
Taizhou 39
Olalla 37
Yubileyny 36
Brooklyn 35
Paris 35
Barcelona 34
Totale 30.684
Salva come PNG Salva come JPEG
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 537
A small molecule targeting the multifactorial nature of Alzheimer's disease 511
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease 423
Integrated analytical approaches for the characterization of Spirulina and Chlorella microalgae 397
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. 394
STABILITY OF ASCORBIC ACID IN COSMETIC FORMULATION: PROTECTIVE ROLE OF RESVERATROL AND MELATONIN 382
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer 333
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 328
Analisi farmaceutica: metodi di riconoscimento e di separazione 322
Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities 297
Advanced analytical methodologies in Alzheimer's disease drug discovery 290
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 287
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) 284
Benzofuran-Based Hybrid Compounds for the Inhibition of Cholinesterase Activity, Abeta Amyloid Aggregation, and Abeta Neurotoxicity 281
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease 263
Influence of high-pressure homogenization treatments combined with lysozyme activated packaging on microbiological and technological quality of vegetable smoothie during shelf life 262
A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: structure-based design, synthesis, and biological evaluation 255
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. 250
INFLUENCE OF AN INNOVATIVE, BIODEGRADABLE MULTILAYER ACTIVE PACKAGING ON “PESTO” SAUCE CHARACTERISTICS DURING STORAGE 248
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine 244
PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION 235
Analisi farmaceutica. Metodi di riconoscimento e di separazione 234
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer 233
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 227
null 222
Influence of an innovative, biodegradable active packaging on the quality of sunflower oil and “pesto” sauce during storage 218
Nature-Inspired Multifunctional Ligands: Focusing on Amyloid-Based Molecular Mechanisms of Alzheimer’s Disease 215
Rational Approach to discover multipotent anti-Alzheimer drugs 214
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors 214
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6 213
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents 210
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties 208
Protective effects of cyanidin-3-O-beta-glucopyranoside against UVA-induced oxidative stress in human keratinocytes. 208
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents 206
Safety issues in nutraceutical exploitation of Chlorella vulgaris, Arthrospira Platensis and Scenedesmus sp. microalgae 200
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues 199
SAR and binding mode at the h-AChE active site of pseudo-irreversible inhibitors related to Xanthostigmine 199
Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects 198
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 198
Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. 197
Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation 196
Development of a new bio-compostable thin film for food packaging with in-line plasma treatment 195
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery? 195
Progettazione e sintesi di derivati poliamminici per il trattamento della malattia di Alzheimer 193
Multitargeted drugs discovery: Balancing anti-amyloid and anticholinesterase capacity in a single chemical entity 192
Determination of levamisole and tetramisole in seized cocaine samples by enantioselective high-performance liquid chromatography and circular dichroism detection 192
Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018 188
EcoPackLab: a new laboratory for the development of new food packaging with long shelf life 187
CHOLINESTERASE INHIBITORS: SAR AND ENZYME INHIBITORY ACTIVITY OF 3-[omega-(BENZYLMETHYLAMINO)ALKOXY]XANTHEN-9-ONES 186
ON-LINE GLYCAN RELEASE AND ANALYSIS BY AN INTEGRATED PNGASE F-IMER LC-ESI-Q-TOF APPROACH 185
Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer's disease 183
Determination of dextromethorphan and levomethorphan in seized heroin samples by enantioselective HPLC and electronic CD 182
AFM study of F-actin on chemically modified surfaces 181
Choosing the right chromatographic support in making a new acetylcholinesterase-micro-immobilised enzyme reactor for drug discovery. 180
Structure-activity relationships of memoquin: Influence of the chain chirality in the multi-target mechanism of action 179
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment. 178
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 175
Analytical characterization of fruits waste for their valorization as sources of bioactive compounds. 174
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases 174
(±)- BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease 174
Monolytic micro-immobilized-enzyme reactor with human recombinant acetylcholinesterase for on-line inhibition studies 173
Novel bis(7)-tacrine derivatives as multitarget ligands: focus on anti-cholinesterase and anti-amyloid activities 173
Stepwise Structural Simplification of the Dihydroxyanthraquinone Moiety of a Multitarget Rhein-Based Anti-Alzheimer Lead to Improve Drug Metabolism and Pharmacokinetic Properties 172
AFM study of F-actin on chemically modified surfaces 172
Bivalent tacrine-based acetylcholinesterase inhibitors: role of the spacer in the recognition process of the enzyme gorge 171
Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks 171
From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease 171
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 170
Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer's Disease 169
Application of BACE1 immobilized enzyme reactor for the characterization of multifunctional alkaloids from Corydalis cava (Fumariaceae) as Alzheimer's disease targets 169
Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors. 169
Development of an UHPLC-diode arrays detector (DAD) method for the analysis of polydatin in human plasma 169
Methotrexate determination in pharmaceuticals by enantioselective HPLC 168
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES 168
Amyloid beta-Peptide 25-35 Self Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment 168
Polyamine Conjugation as a Promising Strategy To Target Amyloid Aggregation in the Framework of Alzheimer’s Disease 168
Simultaneous micellar electrokinetic chromatography of adriblastina and tarabine PFS. Their application to some biological fluids. 167
GC-FID/MS method for the impurity profiling of synthetic d-allethrin. 166
Batch-wise covalent immobilisation of human acetylcholinesterase: kinetic and inhibition spectrophotometric studies 166
Characterization of reversible and pseudo-irreversible Acetylcholinesterase inhibitors by means of immobilized enzyme reactor 166
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates 165
Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimers Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography 165
Derivati a struttura benzofenonica come inibitori dell'acetilcolinesterasi 164
Separation and quantitation of Fructose-6-phosphate and Fructose-1,6-diphosphate by LC-ESI-MS for the evaluation of Fructose-1,6-biphosphatase activity 164
CHOOSING THE RIGHT CHROMATOGRAPHIC SUPPORT FOR ENZYME-BASED MICRO-IMERS. 163
Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer’s disease 163
LC analysis of Oxytetracycline and Chlortetracycline: application for in vitro bio-equivalence study of veterinary medicines 162
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices 162
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease 162
Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts 162
Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 161
Stereoselective analysis of allethrin by two dimensional achiral/chiral HPLC with UV/circular dichroism detection 160
Inhibition of Acetylcholinesterase, Beta-Amyloid Aggregation, and NMDA Receptors in Alzheimer's Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush 160
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice 160
Design, Synthesis and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease Modifying Agents for Alzheimer's Disease 159
Human recombinant beta-secretase immobilized enzyme reactor for fast hits’ selection and characterization from a virtual screening library 159
Comprehensive amino acids profiling of microalgae by gas chromatography-mass spectrometry analysis after pre-column derivatization 159
Simultaneous separation and determination of Tarabine PFS and Adriblastine using micellar electrokinetic chromatography and high performance liquid chromatography. Application to some biological fluids 158
DEVELOPMENT AND CHARACTERIZATION OF A PACKED AChE-micro-IMER FOR DRUG DISCOVERY IN ALZHEIMER’S DISEASE 158
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease 158
Totale 21.135
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.547 0 0 0 0 0 0 0 0 0 218 226 1.103
2021/20225.246 495 188 279 319 456 339 130 385 278 405 1.032 940
2022/20235.517 588 736 308 723 376 391 143 348 910 230 466 298
2023/20242.500 123 295 174 205 190 367 270 403 72 123 157 121
2024/20256.861 325 1.038 712 466 1.351 357 498 275 96 328 292 1.123
2025/202615.441 1.453 1.937 1.648 1.376 1.878 1.018 2.138 484 2.746 763 0 0
Totale 49.710